Vanguard Group Inc Codexis, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,589,213 shares of CDXS stock, worth $13.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,589,213
Previous 4,724,941
2.87%
Holding current value
$13.1 Million
Previous $12.7 Million
11.9%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CDXS
# of Institutions
129Shares Held
69.1MCall Options Held
25.8KPut Options Held
20K-
Opaleye Management Inc. Boston, MA12.6MShares$36 Million7.35% of portfolio
-
Casdin Capital, LLC New York, NY7.2MShares$20.6 Million2.46% of portfolio
-
Black Rock Inc. New York, NY6.79MShares$19.4 Million0.0% of portfolio
-
Abrdn PLC4.2MShares$12 Million0.02% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.03MShares$11.5 Million0.43% of portfolio
About CODEXIS, INC.
- Ticker CDXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,494,100
- Market Cap $187M
- Description
- Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...